Isolagen, Inc. today announced that the Company has submitted a Biologics License Application (BLA) for Isolagen Therapy, a novel, first-in-class cellular therapy for the treatment of wrinkles/nasolabial folds, to the U.S. FDA.
The details can be read here.
No comments:
Post a Comment